Categories: News

AstraZeneca to Lead a Workshop During the Wearable Injectors and Connected Devices Conference 2019

SMi Group are delighted to announce that industry expert Digby Harris, Global Category Manager, AstraZeneca will lead a pre-conference workshop on 8th October in London.

London, United Kingdom, June 07, 2019 –(PR.com)– Workshop Overview:

�Cross Company Collaboration to Develop Digital Therapeutic Solutions Using Connected Devices”

Workshop A – Tuesday 8th October 2019, Copthorne Tara Hotel, London, UK
Digital therapeutics using connected devices are often developed in collaboration between pharma, device and software developers, data platform owners, data providers, wearables and sensor providers and others.

This workshop will focus on reviewing the typical scope and component elements of a digital therapeutic, key considerations of a successful multi-party collaboration, and development of the collaborations of the future.

Benefits of Attending:

This workshop is intended for those who wish to learn more about:
· Collaborating with other parties (including pharma and technology providers) to develop digital therapeutic solutions
· How collaborations are evolving and why

The conference and workshop Agenda is available to download from the event website at www.wearable-injectors.co.uk/prcom2

About the Workshop Leader:
Digby Harris, Global Category Manager, Digital Therapeutics, AstraZeneca
Digby Harris is AstraZeneca’s Global Procurement lead for Digital Therapeutics and has been involved in developing Digital Therapeutics alliances for over 6 years (including connected device development). During that time Digby has also been AstraZeneca’s Global Procurement lead for drug delivery device development. Previously Digby has worked in technology licensing and research collaborations in the Oncology and Respiratory areas.

Secure your attendance and book your place at www.wearable-injectors.co.uk/prcom2

Wearable Injectors and Connected Devices
Conference: 9th – 10th October 2019
Workshops: 8th October 2019
Copthorne Tara Hotel, London, UK
www.wearable-injectors.co.uk/prcom2

Contact Information:
For media enquiries contact Jinna Sidhu on Tel: +44 (0)20 7827 6088 / Email: hsidhu@smi-online.co.uk

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Let’s block ads! (Why?)

Miscw.com

Recent Posts

Zhengzhou: Interactive Exhibitions on the International Museum Day

ZHENGZHOU, China--(BUSINESS WIRE)--In central China’s Zhengzhou city, visiting museums has become a new trend of…

6 hours ago

Reality TV Star, Mollie Pearce, Backs Campaign to Tackle Inequalities in Condition That Impacts Millions of People Globally

Mollie Pearce, star of the UK reality TV show ‘The Traitors’ who was diagnosed with…

16 hours ago

Quality Building Award 2024 Unveils Finalist List

QBA 2024 Announces 35 Finalists Competing for Hong Kong's Highest Honour in the Building Industry…

2 days ago

UXLINK Tops RootData’s Latest X Hot Items List and DappRadar Social Apps List

SINGAPORE - Media OutReach Newswire - 17 May 2024 - UXLINK, the Web3 social platform…

2 days ago

Australia Construction Industry Report 2024: Growth to Slow to 2% in Real-terms this Year Following 9% Growth in 2023 – Forecasts to 2028 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Australia Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to…

2 days ago

Connecting the Dots of ANKTIVA’s Triangle Offense: A Deep Dive with Dr. Patrick Soon-Shiong and Dr. Ashish Kamat in a Three-Part UroToday Podcast

Three-part podcast interview features The mechanism of action of ANKTIVA® activating NK cells, Killer T…

2 days ago